Witold Kycler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Witold Kycler has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Agata Kubicka
Department of Cancer Pathology, Greater Poland Cancer Centre, Garbary 15, 61-866 Poznan, Poland
1 shared publication - Agnieszka Dołhań
Department of Pharmaceutical Chemistry
1 shared publication Agnieszka Lis
Department of Radiology, Greater Poland Cancer Centre, Poznan, Poland
1 shared publicationAlicja Bukowska
Medical Analysis Laboratory, Regional Blood Center, Poznań, Poland
1 shared publication- Alicja Rzymska
Students’ Scientific Society, Poznan University of Medical Sciences, 60-781 Poznan, Poland
1 shared publication - Anna Jelińska
Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 17 June 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (3) , 1073-1076
Limited confidence in cervical cancer screening – unusually increased carcinoembryonic antigen expression resulting in the rapid development of cervical intraepithelial neoplasia grade 2
- 17 June 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (3) , 1073-1076
Open AccessLimited confidence in cervical cancer screening – unusually increased carcinoembryonic antigen expression resulting in the rapid development of cervical intraepithelial neoplasia grade 2
- Open Access
- 7 May 2025
- Published by Termedia Sp. z.o.o. in Polish Journal of Radiology
- Vol. 90, 207-214
Advancing clinical staging in invasive breast carcinoma: the role of contrast-enhanced mammography
Purpose: This study compares breast carcinoma (BC) clinical tumour staging by contrast-enhanced mammography (CEM), full-field digital mammography (FFDM), and ultrasound (US). Clinical staging is essential for multidisciplinary teams to develop optimal treatment plans and for cancer registries to generate accurate analyses of cancer epidemiology.Material and methods: Data on tumour size and the presence of multiplicity were extracted from radiology reports. Primary tumour staging (cT category) was established for each imaging modality. Enrolled cases (n = 78, adult females) had FFDM and US performed up to a month prior to CEM. Fisher’s exact test was used to examine the relationship between cT stage determination and diagnostic methods.Results: Tumour size was largest in CEM (median 47 mm), followed by FFDM (median 33 mm), and smallest in US (median 23 mm). There were statistically significant differences in the distribution of cT categories between the 3 imaging modalities, with cT2 and cT1 being most common in US (46% and 41%, respectively) and FFDM (53% and 19%, respectively). Staging by CEM followed a different pattern, with cT2 and cT3 being most common (both 38%). The multiplicity rate was equal for CEM and US (42%), with fewer cases in FFDM (13%).Conclusions: The tumour size measured by CEM is greater compared to measurements obtained through US and FFDM. Given the strong correlation between CEM and histopathology reported in the literature, CEM enhances the accuracy of local tumour staging in BC, thereby minimising the risk of understaging.
- 7 May 2025
- Published by Termedia Sp. z.o.o. in Polish Journal of Radiology
- Vol. 90, 207-214
Open AccessAdvancing clinical staging in invasive breast carcinoma: the role of contrast-enhanced mammography
Purpose: This study compares breast carcinoma (BC) clinical tumour staging by contrast-enhanced mammography (CEM), full-field digital mammography (FFDM), and ultrasound (US). Clinical staging is essential for multidisciplinary teams to develop optimal treatment plans and for cancer registries to generate accurate analyses of cancer epidemiology.Material and methods: Data on tumour size and the presence of multiplicity were extracted from radiology reports. Primary tumour staging (cT category) was established for each imaging modality. Enrolled cases (n = 78, adult females) had FFDM and US performed up to a month prior to CEM. Fisher’s exact test was used to examine the relationship between cT stage determination and diagnostic methods.Results: Tumour size was largest in CEM (median 47 mm), followed by FFDM (median 33 mm), and smallest in US (median 23 mm). There were statistically significant differences in the distribution of cT categories between the 3 imaging modalities, with cT2 and cT1 being most common in US (46% and 41%, respectively) and FFDM (53% and 19%, respectively). Staging by CEM followed a different pattern, with cT2 and cT3 being most common (both 38%). The multiplicity rate was equal for CEM and US (42%), with fewer cases in FFDM (13%).Conclusions: The tumour size measured by CEM is greater compared to measurements obtained through US and FFDM. Given the strong correlation between CEM and histopathology reported in the literature, CEM enhances the accuracy of local tumour staging in BC, thereby minimising the risk of understaging.
- 11 March 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (5) , 103205
Significance of the Monocyte CCR2-CCL2 Axis in Triple-negative Breast Cancer
- 11 March 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (5) , 103205
Significance of the Monocyte CCR2-CCL2 Axis in Triple-negative Breast Cancer
- Open Access
- 4 August 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-8
The Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
Eplerenone was subjected to the influence of ionizing radiation in the form of a high-energy electron beam (25–400 kGy), high temperature (90°C RH 0% and 60°C RH 76.4%), and light (6 mln lux h). An HPLC method was used to determine the content of eplerenone and to establish the impurity profile of all samples. As eplerenone was found to be a compound of great resistance to the above stress factors with the exception of high doses of ionizing radiation (≥200 kGy) when its degradation was above 1%, it is possible to sterilize eplerenone by radiation method with the standard dose of 25 kGy. Based on the analysis of impurities and degradation products, the mechanism of radiodegradation was demonstrated to differ from the mechanisms of photo- and thermodegradation. The observation that the DSC curves for the nondegraded and degraded samples of eplerenone were significantly different only under exposure to the electron beam confirmed the applicability of DSC for studies of radiolytic degradation of eplerenone.
- 4 August 2014
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-8
Open AccessThe Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
Eplerenone was subjected to the influence of ionizing radiation in the form of a high-energy electron beam (25–400 kGy), high temperature (90°C RH 0% and 60°C RH 76.4%), and light (6 mln lux h). An HPLC method was used to determine the content of eplerenone and to establish the impurity profile of all samples. As eplerenone was found to be a compound of great resistance to the above stress factors with the exception of high doses of ionizing radiation (≥200 kGy) when its degradation was above 1%, it is possible to sterilize eplerenone by radiation method with the standard dose of 25 kGy. Based on the analysis of impurities and degradation products, the mechanism of radiodegradation was demonstrated to differ from the mechanisms of photo- and thermodegradation. The observation that the DSC curves for the nondegraded and degraded samples of eplerenone were significantly different only under exposure to the electron beam confirmed the applicability of DSC for studies of radiolytic degradation of eplerenone.